Clinical and genetic characteristics of two patients with tyrosinemia type 1 in Slovenia - A novel fumarylacetoacetate hydrolase (FAH) intronic disease-causing variant.
Mol Genet Metab Rep
; 30: 100836, 2022 Mar.
Article
em En
| MEDLINE
| ID: mdl-35242570
AFP, alpha-fetoprotein; ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; DBS, dried blood spot; Dried blood spot; FAH, fumarylacetoacetate hydrolase; Fumarylacetoacetate hydrolase; GGT, gamma glutamyl transferase; HT1, tyrosinemia type 1; INR, international normalized ratio; Intronic variant; MS/MS, tandem mass spectrometry; NBS, newborn screening; NTBC, nitisinone; Nitisinone; PTT, partial thromboplastin time; RF, reference range; SA, succinylacetone; Succinylacetone; Tyrosinemia
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Mol Genet Metab Rep
Ano de publicação:
2022
Tipo de documento:
Article